跳至主要内容
临床试验/NL-OMON49032
NL-OMON49032已完成不适用

Transcranial Alternating Current Stimulation (tACS) as a novel treatment option: a proof of concept study in Adult Classic Galactosemia - Non Invasive Brain Stimulation in Adolescent Classic Galactosemia

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patient group:
  • The patient may participate in the study, if they meet these criteria:
  • - Adult age: 18 years or older
  • - GALT enzyme activity below 10% and/or GALT gene severe disease causing
  • - Motor sequencing and/or word productions problems
  • - Documented motor and language impairments
  • - Capable of giving informed consent
  • - The participants are screened pre and post intervention using standardized
  • tests. Participants with abnormal scores in cognitive and/or motor domains are
  • Control group:
  • Healthy controls are included if they meet the following criteria:
  • - Adult age: 18 years or older
  • - No motor, language and/or cognitive impairments
  • - Capable of giving informed consent

排除标准

  • - Motor and language problems due to other causes
  • - Psoriasis
  • - Epilepsy

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验